Genetic alterations in prostate cancer.
Prostate cancer is the number one malignancy among men. The search for causative factors has proven to be difficult and, accordingly, treatment options for advanced prostate cancer remain limited. However, technologic breakthroughs in the fields of genetics and molecular biology have advanced our understanding of the mechanisms involved in prostate carcinogenesis. The aim of this article is to review the most recent evidence for the role of various genetic insults at specific steps in tumor formation and to suggest potential therapeutic targets.
Chin
Jonathan L
JL
Department of Urology, David Geffen School of Medicine, University of California at Los Angeles, 650 Charles East Young Drive, Room 66-134 CHS, Los Angeles, CA 90095, USA.
Reiter
Robert E
RE
D006801:Humans; D008297:Male; D009363:Neoplasm Proteins / Q000235:genetics; D011110:Polymorphism, Genetic / Q000235:genetics; D011471:Prostatic Neoplasms / Q000201:enzymology / Q000235:genetics* / Q000628:therapy
D009363:Neoplasm Proteins